Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: A systematic review and meta-analysis

European Journal of Cardio-thoracic Surgery

Volumn 52, Issue 1, 2017, Pages 14-25

  den Uil, Corstiaan A ^a   Akin, Sakir ^a   Jewbali, Lucia S ^a   ReisMiranda, Dinis dos ^a   Brugts, Jasper J ^a   Constantinescu, Alina A ^a   Kappetein, Arie Pieter ^a   Caliskan, Kadir ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cardiogenic shock; Heart failure; Left ventricular assist device; Mechanical circulatory support

Indexed keywords

ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CLINICAL EFFECTIVENESS; EXTRACORPOREAL OXYGENATION; HUMAN; IMPLANTATION; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SHORT COURSE THERAPY; SYSTEMATIC REVIEW; COMPLICATION; HEART ASSIST DEVICE; HEART FAILURE; PROCEDURES; TIME FACTOR;

ASSISTED CIRCULATION; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; SHOCK, CARDIOGENIC; TIME FACTORS;

EID: 85021709460     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezx088     Document Type: Review

References (48)

1. Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK et al. 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention. J Am Coll Cardiol 2015;65:e7-26
2. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129-200
3. Pagani FD, Lynch W, Swaniker F, Dyke DB, Bartlett R, Koelling T et al. Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization. Circulation 1999;100:II206-10
4. Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb S et al. The registry of the International Society for Heart and Lung Transplantation: thirty-second official adult heart transplantation report-2015; focus theme: early graft failure. J Heart Lung Transplant 2015;34:1244-54
5. Liberati A, Altman DG, TetzlaffJ, Mulrow C, Gotzsche PC, Ioannidis JP et al. The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700
6. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13
7. Higgins J, SG. Cochrane Handbook for Systematic Reviews of Interventions. Version 501. 2008. The Cochrane Collaboration. www. cochrane-handbook.org
8. Iqbal MB, Robinson SD, Ding L, Fung A, Aymong E, Chan AW et al. Intra-aortic balloon pump counterpulsation during primary percutaneous coronary intervention for ST-elevation myocardial infarction and cardiogenic shock: insights from the British Columbia Cardiac Registry. PLoS One 2016;11:e0148931
9. Timoteo AT, Nogueira MA, Rosa SA, Belo A, Ferreira RC; ProACS Investigators. Role of intra-aortic balloon pump counterpulsation in the treatment of acute myocardial infarction complicated by cardiogenic shock: evidence from the Portuguese nationwide registry. Eur Heart J Acute Cardiovasc Care 2016;5:23-31
10. Zeymer U, Hochadel M, Hauptmann KE, Wiegand K, Schuhmacher B, Brachmann J et al. Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry. Clin Res Cardiol 2013;102:223-7
11. Sjauw KD, Engstrom AE, Vis MM, Boom W, Baan J Jr, de Winter RJ et al. Efficacy and timing of intra-aortic counterpulsation in patients with STelevation myocardial infarction complicated by cardiogenic shock. Neth Heart J 2012;20:402-09
12. Vandenplas G, Bove T, Caes F, Van Belleghem Y, Francois K, De Somer F et al. Ten years single-centre experience with intra-aortic balloon pump. Acta Cardiol 2011;66:707-13
13. Zeymer U, Bauer T, Hamm C, Zahn R, Weidinger F, Seabra-Gomes R et al. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI. EuroIntervention 2011;7:437-41
14. Cheng JM, Valk SD, den Uil CA, van der Ent M, Lagrand WK, van de Sande M et al. Usefulness of intra-aortic balloon pump counterpulsation in patients with cardiogenic shock from acute myocardial infarction. Am J Cardiol 2009;104:327-32
15. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012;367:1287-96
16. Tanaka A, Tuladhar SM, Onsager D, Asfaw Z, Ota T, Juricek C et al. The Subclavian intraaortic balloon pump: a compelling bridge device for advanced heart failure. Ann Thorac Surg 2015;100:2151-7; discussion 7-8
17. Estep JD, Cordero-Reyes AM, Bhimaraj A, Trachtenberg B, Khalil N, Loebe M et al. Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory longterm support as bridge to heart transplantation. JACC Heart Fail 2013;1:382-8
18. Krishnamoorthy A, DeVore AD, Sun JL, Barnett AS, Samsky MD, Shaw LK et al. The impact of a failing right heart in patients supported by intraaortic balloon counterpulsation. Eur Heart J Acute Cardiovasc Care 2016
19. Ntalianis A, Kapelios CJ, Kanakakis J, Repasos E, Pantsios C, Nana E et al. Prolonged intra-aortic balloon pump support in biventricular heart failure induces right ventricular reverse remodeling. Int J Cardiol 2015;192:3-8
20. Berg DD, Sukul D, O'Brien M, Scirica BM, Sobieszczyk PS, Olenchock BA et al. Outcomes in patients undergoing percutaneous ventricular assist device implantation for cardiogenic shock. Eur Heart J Acute Cardiovasc Care 2016;5:108-16
21. Froesch P, Martinelli M, Meier P, Cook S, Hullin R, Windecker S et al. Clinical use of temporary percutaneous left ventricular assist devices. Catheter Cardiovasc Interv 2011;78:304-13
22. Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol 2011;57:688-96
23. Brinkman WT, Rosenthal JE, Eichhorn E, Dewey TM, Magee MJ, Savor DS et al. Role of a percutaneous ventricular assist device in decision making for a cardiac transplant program. Ann Thorac Surg 2009;88:1462-6
24. BurkhoffD, Cohen H, Brunckhorst C, O'Neill WW; TandemHeart Investigators Group. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006;152:469.e1-68
25. Lauten A, Engstrom AE, Jung C, Empen K, Erne P, Cook S et al. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail 2013;6:23-30
26. O'Neill WW, Schreiber T, Wohns DH, Rihal C, Naidu SS, Civitello AB et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol 2014;27:1-11
27. Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008;52:1584-8
28. Engstrom AE, Cocchieri R, Driessen AH, Sjauw KD, Vis MM, Baan J et al. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience. Crit Care Med 2011;39:2072-9
29. Liu W, Mukku VK, Gilani S, Fujise K, Barbagelata A. Percutaneous hemodynamic support (Impella) in patients with advanced heart failure and/or cardiogenic shock not eligible to PROTECT II trial. Int J Angiol 2013;22:207-12
30. Casassus F, Corre J, Leroux L, Chevalereau P, Fresselinat A, Seguy B et al. The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction. J Interv Cardiol 2015;28:41-50
31. Lima B, Kale P, Gonzalez-Stawinski GV, Kuiper JJ, Carey S, Hall SA. Effectiveness and safety of the Impella 5.0 as a bridge to cardiac transplantation or durable left ventricular assist device. Am J Cardiol 2016;117:1622-8
32. Mastroianni C, Bouabdallaoui N, Leprince P, Lebreton G. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salp^etriè re. Eur Heart J Acute Cardiovasc Care 2017;6:87-92
33. Gaudard P, Mourad M, Eliet J, Zeroual N, Culas G, Rouviere P et al. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock. Crit Care 2015;19:363
34. Lamarche Y, Cheung A, Ignaszewski A, Higgins J, Kaan A, Griesdale DE et al. Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support. J Thorac Cardiovasc Surg 2011;142:60-5
35. Takayama H, Soni L, Kalesan B, Truby LK, Ota T, Cedola S et al. Bridgeto-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. Circ Heart Fail 2014;7:799-806
36. John R, Long JW, Massey HT, Griffith BP, Sun BC, Tector AJ et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg 2011;141:932-9
37. De Robertis F, Rogers P, Amrani M, Petrou M, Pepper JR, Bahrami T et al. Bridge to decision using the Levitronix CentriMag short-term ventricular assist device. J Heart Lung Transplant 2008;27:474-8
38. Worku B, Pak SW, van Patten D, Housman B, Uriel N, Colombo P et al. The CentriMag ventricular assist device in acute heart failure refractory to medical management. J Heart Lung Transplant 2012;31:611-7
39. Muller G, Flecher E, Lebreton G, Luyt CE, Trouillet JL, Brechot N et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med 2016;42:370-8
40. Tarzia V, Bortolussi G, Bianco R, Buratto E, Bejko J, Carrozzini M et al. Extracorporeal life support in cardiogenic shock: Impact of acute versus chronic etiology on outcome. J Thorac Cardiovasc Surg 2015;150:333-40
41. Carroll BJ, Shah RV, Murthy V, McCullough SA, Reza N, Thomas SS et al. Clinical Features and outcomes in adults with cardiogenic shock supported by extracorporeal membrane oxygenation. Am J Cardiol 2015;116:1624-30
42. Beurtheret S, Mordant P, Paoletti X, Marijon E, Celermajer DS, Leger P et al. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J 2013;34:112-20
43. Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, Leger P et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 2008;36:1404-11
44. Lorusso R, Centofanti P, Gelsomino S, Barili F, Di Mauro M, Orlando P et al. Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience. Ann Thorac Surg 2016;101:919-26
45. Diddle JW, Almodovar MC, Rajagopal SK, Rycus PT, Thiagarajan RR. Extracorporeal membrane oxygenation for the support of adults with acute myocarditis. Crit Care Med 2015;43:1016-25
46. Hsu KH, Chi NH, Yu HY, Wang CH, Huang SC, Wang SS et al. Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center's experience. Eur J Cardiothorac Surg 2011;40:682-8
47. Sandhu A, McCoy LA, Negi SI, Hameed I, Atri P, Al'Aref SJ et al. Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention: insights from the National Cardiovascular Data Registry. Circulation 2015;132:1243-51
48. Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LS, van Domburg RT et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 2009;30:2102-8